News | April 27, 2020

HARPOON THERAPEUTICS DOSES FIRST PATIENT WITH HPN217, A BCMA TARGETING TRITAC, FOR MULTIPLE MYELOMA Initiation of the clinical trial triggers $50 million milestone payment from AbbVie SOUTH SAN FRANCISCO, Calif., April 27, 2020 (GLOBE NEWSWIRE) — Harpoon...

News | April 16, 2020

TigerConnect Launches TigerTouch Video and Voice Telehealth Features to Help Hospitals Combat COVID-19 TigerTouch simplifies telehealth for patients with video, voice, and text messaging in a single smartphone-friendly user experience SANTA MONICA, California — April...

News | April 6, 2020

BrightInsight Named 2019 Google Cloud Technology Partner of the Year for the Healthcare Industry for Second Year in Row Built on Google Cloud Platform, the BrightInsight Platform supports and optimizes regulated drugs, devices and software through integrated data and...

News | March 31, 2020

Iterum Therapeutics Provides Update on Phase 3 Clinical Trials of Sulopenem in Complicated Urinary Tract Infection (cUTI) and Uncomplicated Urinary Tract Infection (uUTI) Topline results from uUTI and cUTI clinical trials to be announced in Q2 2020 Iterum Therapeutics...

News | February 12, 2020

Deciphera Pharmaceuticals Announces U.S. Food and Drug Administration Acceptance of New Drug Application and Priority Review for Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors – FDA Grants Priority Review and sets PDUFA Date of August 13,...